Georg Hess, MD^1*, Martin Dreyling, MD², Lucie Oberic, MD^3*, Eva Gine, MD, PhD⁴, Pier Luigi Zinzani, MD, PhD⁵, Kim M. Linton^6*, Adam Vilmar, MD^7*, Mats Jerkeman, MD, PhD⁸, Jenny MH Chen^9*, Anke Ohler, PhD^1*, Stephan Stilgenbauer^10*, Catherine Thieblemont, MD, PhD¹¹, Jonathan Lambert^12*, Vittorio Ruggero Zilioli, MD^13*, Juan-Manuel Sancho, MD, PhD^14*, Ana Jimenez-Ubieto, MD, PhD^15*, Luca Fischer, MD^2*, Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD^16*, Sam Keeping, MSc^9*, Julie E Park, MMath^9*, James J Wu, MSc^17*, Rubina Siddiqi, PhD, MBA^17*, John Reitan^18*, Gab Castaigne, PhD^19* and Gilles Salles, MD, PhD²⁰

¹Department of Hematology, Oncology and Pneumology, Comprehensive Cancer Center, University Medical School of the Johannes Gutenberg-University, Mainz, Germany
²Medizinische Klinik III, LMU Klinikum, Munich, Germany
³Department of Hematology, Institut Universitaire Cancerologie Toulouse-Oncopole, Toulouse, France
⁴GELTAMO, Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain
⁵IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy
⁶The Manchester Cancer Research Center, Manchester, United Kingdom
⁷Odense University Hospital, Odense, Denmark
⁸Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden
⁹PRECISIONheor, Vancouver, BC, Canada
¹⁰Department of Internal Medicine III, Ulm University, Ulm, Germany
¹¹Hemato-oncology Department, Université de Paris Cité/Saint-Louis University Hospital/AP-HP, Paris, France
¹²University College London Hospitals NHS Foundation Trust, London, ENG, United Kingdom
¹³Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, IT-MI, Italy
¹⁴GELTAMO, Institut Català d’Oncologia, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁵GELTAMO, Hospital Doce de Octubre, Madrid, Spain
¹⁶Oxford University Hospitals, Oxford, United Kingdom
¹⁷Kite, a Gilead Company, Santa Monica, CA
¹⁸RJM Group, LLC, Crown Point, IN
¹⁹Kite, a Gilead Company, London
²⁰Memorial Sloan Kettering Cancer Center, New York, NY

Liora M. Schultz, MD¹, Sneha Ramakrishna, MD², Reema Baskar, PhD^3*, Rebecca M Richards, MD, PhD⁴, Jennifer Moon, jmoon@stanfordchildrens.org^5*, Christina Baggott, RN, PhD^6*, Michelle Fujimoto^7*, Michael Kunicki^5*, Amy Li, ali4@stanford.edu^8*, Sneha Jariwala^9*, Courtney Erickson^5*, Ashley Jacobs^9*, Karen Yamabe^10*, Valentin Barsan^10*, Robbie G. Majzner, MD¹¹, Emily L. Egeler, PhD^12*, Sharon Mavroukakis^13*, Zachary Ehlinger, MS^14*, Warren D. Reynolds, BS^14*, Bita Sahaf, PhD^12*, Lori Muffly, MD¹⁵, Matthew J Frank, MD, PhD¹⁶, Anne-Louise Gramstrup^17*, Harshini Chinnasamy, MS^12*, Shabnum Patel, PhD^3*, David B. Miklos, MD, PhD¹⁸, Steven A. Feldman, PhD^12*, Crystal L. Mackall, MD¹⁹ and Kara L. Davis, D.O.²⁰

¹Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
²Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Stanford, CA
³Stanford University School of Medicine, Palo Alto, CA
⁴Department of Pediatrics, Stanford University, Palo Alto, CA
⁵Stanford University School of Medicine, Department of Pediatrics, Division of Hematology and Oncology, Palo Alto, CA
⁶Stanford University School of Medicine, Stanford, CA
⁷Stanford University, Cancer Clinical Trials Office, CCTO, Palo Alto, CA
⁸Stanford University School of Medicine, Department of Pediatrics, Palo Alro, CA
⁹Stanford University School of Medicine, Department of Pediatrics, Palo Alto, CA
¹⁰Stanford University School of Medicine, Department of Pediatrics, Palo Alto
¹¹Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA
¹²Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
¹³Stanford University Medical Center School of medicine, Stanford, CA
¹⁴Center for Cancer Cell Therapy, Stanford University, Stanford, CA
¹⁵Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
¹⁶Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA
¹⁷Stanford University School, Palo Alto
¹⁸Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Hospital, Stanford, CA
¹⁹Divisions of Hematology and Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
²⁰Department of Pediatrics, Hematology, Oncology, and Stem Cell Transplant and Regenerative Medicine, Stanford University, Stanford, CA

Joseph P. McGuirk, DO¹, Constantine S. Tam^2*, Nicolaus Kröger, MD^3*, Peter A. Riedell, MD⁴, Hemant S. Murthy, MD⁵, Phoebe Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA)^6*, Joseph E. Maakaron, MD⁷, Edmund K. Waller, MD, PhD⁸, Farrukh T. Awan, MD⁹, Paul J. Shaughnessy, MD¹⁰, Armin Ghobadi, MD¹¹, Michael R. Bishop, MD¹², Ana Alfonso-Pierola, MD, PhD^13*, Michael Dickinson, MD¹⁴, Praveen Ramakrishnan Geethakumari, MD, MS^15,16, Ainsley Ross, MPH^17*, William Stevens, MS^17*, Huansheng Xu, PhD^17*, Anna Ma, MS^17*, Sarah Beaussant Cohen, MD^17*, Richard T. Maziarz, MD¹⁸ and Carlos Bachier, MD¹⁰

¹Department of Blood and Bone Marrow Transplant, The University of Kansas Medical Center, Kansas City, KS
²Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia
³University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
⁴Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁵Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
⁶Royal Prince Alfred Hospital and University of Sydney, Camperdown, Sydney, NSW, Australia
⁷Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, MN
⁸Winship Cancer Institute, Emory University, Atlanta, GA
⁹Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
¹⁰Sarah Cannon Transplant and Cellular Therapy Program, Methodist Hospital, San Antonio, TX
¹¹Center for Gene and Cellular Immunotherapy (CGCI), Washington University School of Medicine, St. Louis, MO
¹²Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL
¹³Department of Oncology-Hematology, Centro de Investigación Médica Aplicada (CIMA), Navarra university-IDISNA. Centro de Investigación Biomédica en Red de Cáncer, CIBERONC. Clínica Universidad de Navarra, Pamplona, Spain
¹⁴Peter MacCallum Cancer Centre and Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia
¹⁵Harold C. Simmons Comprehensive Cancer Center, Dallas, TX
¹⁶Division of Hematologic Malignancies and Stem Cell Transplantation, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
¹⁷CRISPR Therapeutics, Boston, MA
¹⁸Knight Cancer Institute, Oregon Health and Science University, Portland, OR

Hui Liu, MD^1*, Ting Wang^2*, Yazi Yang^2*, Ru Feng, MD^1*, Jiangtao Li^2*, Chunli Zhang^2*, Jiefei Bai, MD^2*, Yanping Ding, PhD^3*, Guanghua Liu, PhD^3*, Fei Wu^3*, Xinan Lu, PhD^3*, Jian Li, MD⁴ and Ting He, PhD^3*

¹Department of Hematology, Beijing Hospital, Beijing, China
²Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, China
³Beijing Imunopharm Technology Co., Ltd., Beijing, China
⁴Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Pere Barba, MD^1*, Elisa Roldan, MD^2,3*, María Suárez-Lledó, MD^4*, Juan Montoro Gomez^5*, Santiago Perez-Hoyos^6*, Alberto Mussetti^7*, Christelle Ferra^8*, Ruth Coll^9*, Luciano Rodriguez^10*, Julia Marsal^11*, Rodrigo Martino, MD^12*, Julio Castaño, PhD^13*, Marga Codinach^10*, Francesc Bosch, MD, PhD^14,15, Ramon Gimeno^16*, David Valcarcel, MD, PhD^17,18, Francesc Rudilla^19* and Sergio Querol^20*

¹Department of Hematology, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
²Hematology Department. Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom
³Hematology Department, Department of Hematology. Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron., Barcelona, Spain, Barcelona, Spain
⁴Hematopoietic Transplantation Unit and Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), IDIBAPS, Hospital Clínic de Barcelona, Barcelona, Spain
⁵Hospital Universitario La Fe, Valencia, Spain
⁶Statistics Department, Vall Hebron Research Institute, Barcelona, Spain
⁷Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
⁸Institut Català d´Oncologia-H. Germans Trias i Pujol, Badalona, Spain
⁹Banc de Sang i Teixits de Catalunya, BARCELONA, Spain
¹⁰Banc de Sang i Teixits de Catalunya, Barcelona, Spain
¹¹Hospital Sant Joan de Deu, Barcelona, Spain
¹²Servei d'Hematologia. Hospital Sant Creu i Sant Pau, Barcelona, Spain
¹³Immunotherapy Unit, Banc de Sang i Teixits, Barcelona, Spain
¹⁴1. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Departament de Medicina, Universitat Autònoma de Barcelona,, Barcelona, Spain
¹⁵Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
¹⁶Immunology, Hospital del Mar, Barcelona, Spain
¹⁷Hematology Department, Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron, University Hospital, Barcelona, Spain
¹⁸Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
¹⁹Banc de Sang i Teixits de Catalunya, Barcelona, AL, ESP
²⁰Catalan Blood and Tissue Bank, Barcelona, ESP

Qiuxia Yu^1*, Xiaoying Zhang^2*, Na Wang, MD, PhD^3*, Liang Huang, MD⁴, Chunrui Li, MD, PhD⁵, Yicheng Zhang, MD, PhD⁴, Jianfeng Zhou, MD^6*, Gaoxiang Wang, MD^4* and Yang Cao^7*

¹Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wu Han, AL, China
²Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech, Wuhan, China
³Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
⁴Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁵Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁶Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CHN
⁷Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, CA, China

David A. Sallman, MD¹, Hany Elmariah, MD, MS², Kendra Sweet, MD¹, Asmita Mishra, MD³, Cheryl A Cox^4*, Marion Chakaith^5*, Roshanak Semnani, PhD^6*, Sheeba Shehzad^5*, Asha Anderson^5*, Helen Sabzevari, PhD^6*, Amy Lankford, PhD^6*, Onyee Chan, MD⁷, Luis SanchezMolina^8*, Chen Wang, MD^9*, Eric Padron, MD¹, Andrew Kuykendall, MD¹⁰, Rami S. Komrokji⁷, Jeffrey E. Lancet, MD⁷, Marco L. Davila, MD, PhD¹¹ and Nelli Bejanyan, MD¹²

¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
²Moffitt Cancer Center, Tampa, FL
³Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
⁴Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL
⁵Precigen, Inc, Germantown
⁶Precigen, Inc, Germantown, MD
⁷Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁸Moffitt Cancer Center, Tampa
⁹Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL
¹⁰Department of Malignant Hematology, H. Lee Mofitt Cancer Center, Tampa, FL
¹¹Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹²Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL

Kate Cwynarski, MD^1*, Gloria Iacoboni, MD^2,3*, Eleni Tholouli, MD, MRCPath^4*, Tobias F. Menne, MD PhD^5*, David A. Irvine, BSc, MBBChir, MRCP, FRCPath, PhD⁶, Nivetha Balasubramaniam^7*, Leigh Wood, BA^7*, Justin Shang, PhD^8*, Yiyun Zhang, PhD^8*, Silvia Basilico, PhD^9*, Birgit Huber, PhD^9*, Mary Vinson, PhD^9*, Koki Lilova, PhD^9*, Wolfram Brugger, MD⁹ and Martin Pule, MD^9,10*

¹University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Department of Hematology, University Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, WA, Spain
³Department of Hematology, Hospital Universitario Vall d'Hebron, Vall d’Hebron Institute of Oncology, Barcelona, Spain
⁴Department of Haematology, Manchester Royal Infirmary, Manchester, United Kingdom
⁵The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, United Kingdom
⁶Queen Elizabeth University Hospital, Glasgow, Scotland, GBR
⁷University College London Hospital, London, United Kingdom
⁸Autolus Inc, Rockville, MD
⁹Autolus Ltd, London, United Kingdom
¹⁰Department of Haematology, University College London Hospital, London, United Kingdom

Olalekan O. Oluwole, MBBS¹, Saad S. Kenderian, MD², Parveen Shiraz, MD³, Reem Karmali, MD, MSc⁴, Ran Reshef, MD, MSc⁵, Philip L. McCarthy, MD⁶, Nilanjan Ghosh, MD⁷, Aleksandr Lazaryan, MD, PhD, MPH⁸, Simone Filosto, PhD^9*, Soumya Poddar, PhD^9*, Daqin Mao, PhD^9*, Andrew Peng, MS^9*, Adrian Kilcoyne, MD, MPH^10*, Myrna Nahas, MD^9* and Sattva S. Neelapu, MD¹¹

¹Vanderbilt University Medical Center, Nashville, TN
²Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
³Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
⁴Division of Hematology/Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL
⁵Blood and Marrow Transplantation Program, Columbia University, New York, NY
⁶Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁸Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁹Kite, a Gilead Company, Santa Monica, CA
¹⁰Humanigen, Inc., Burlingame, CA
¹¹Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

Mengyi Du^1,2*, Chenggong Li^3,4*, Fen Zhou^5*, Wenjing Luo^2,3*, Yinqiang Zhang^2,3*, Lu Tang^3,4*, Jianghua Wu^3*, Huiwen Jiang^3,4*, Qiuzhe Wei^3,4*, Haiming Kou^2,3*, Cong Lu^2,3*, Chunrui Li, MD, PhD³, Heng Mei^2,3* and Yu Hu, MD^4,6*

¹nstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
³Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁴Hubei clinical medical center of cell therapy for neoplastic disease, Wuhan, China
⁵Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁶Union Hospital,Tongji Medical College,Huazhong University of Science and Technology, Wuhan, China

Sébastien Anguille^1*, Ilse Kuipers^2*, Kirsten Saevels, MD³, Yves Beguin, MD, PhD⁴, Anna Van Muyden, MSc^5*, Christian Jacques, MD⁵ and Marie Jose Kersten, MD, PhD²

¹Division of Hematology and Center for Cell Therapy & Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium
²Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, Netherlands
³Division of Hematology, Antwerp University Hospital, Antwerp, Belgium
⁴Department of Hematology, CHU Liege, University of Liege, Liege, Belgium
⁵CellPoint, a Galapagos company, Leiden, Netherlands

Giuseppe Gritti, MD, PhD^1*, Federico Lussana, MD, PhD^1*, Silvia Ferrari, MD^1*, Anna Maria Barbui^1*, Francesco Landi^1*, Giulia Quaresmini^2*, Gianmaria Borleri^1*, Muriel Paganessi^1*, Chiara Pavoni, MSc^1*, Elisa Gotti^3*, Chiara Capelli^4*, Josee Golay, PhD, BA^3*, Martino Introna, MD³ and Alessandro Rambaldi, MD^2,5

¹Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
²Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy
³Centro di Terapia Cellulare "G. Lanzani", Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁴Fondazione per la Ricerca Ospedale di Bergamo (FROM), Bergamo, Italy
⁵Department of Oncology and Hematology, University of Milan, Milan, Italy

Mark Juckett, MD¹, Sham Mailankody, MBBS ², Alireza Eghtedar, MD^3*, Cara Bickers, PhD^4*, Xingyue Zong, PhD^4*, Lilly Wong, PhD^4*, Thomas Ly, PhD^4*, John Byon, MD, PhD⁴, Sarah Cooley, MD⁴, Bahram Valamehr⁴, Yu-Waye Chu, MD⁴ and Ravi Vij, MD, MBBS⁵

¹Masonic Cancer Center, University of Minnesota, Minneapolis, MN
²Memorial Sloan Kettering Cancer Center, New York, NY
³Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center, Denver, CO
⁴Fate Therapeutics, Inc., San Diego, CA
⁵Siteman Cancer Center, Washington University, St Louis, MO

Yuqin Song, MD¹, Zhitao Ying^1*, Haiyan Yang^2*, Ye Guo^3*, Wenyu Li⁴, Dehui Zou, M.D., Ph.D.^5*, Jianqiu Wu, MD^6*, Alex Tian^7*, Tony Huang^7*, Zisong Zhou^7*, Meilin Ma^7*, Su Yang^7*, Yun Qin^7* and Jun Zhu, PhD¹

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of Medical Oncology, Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Hangzhou, China
³Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
⁴Department of Lymphoma, Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangdong, China
⁵Department of Lymphoma & Myeloma, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union of Medical College, Tianjin, China
⁶Department of Medical Oncology, Jiangsu Institute of Cancer Research, Jiangsu Red Cross Cancer Center, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, China
⁷JW Therapeutics (Shanghai) Co. Ltd, Shanghai, China

Hasmukh Jain, MD, DM^1*, Atharva Karulkar, PhD^2*, Neha Sharma^1*, Manju Sengar, MD, DM ³, Ankesh Jaiswal^4*, Shreshtha Shah^2*, Aalia Khan^4*, Afrin Firfiray^4*, Sweety Asija^4*, Prashant Suvasia^4*, Priyanshi Suvasia^4*, Juber Pendhari^4*, Devanshi Kalra^5*, Smrithi Ravikumar^2*, Gaurav Narula, MD^6*, Shripad Banavali^7*, Minal Poojary, MD^8*, Sumathi Hiregoudar, MD^9*, Lingaraj Nayak, MD, DM^10*, Bhausaheb Bagal, MD, DM^11*, Prashant R. Tembhare, MD¹², Sridhar Epari^13*, Navin Khattry, MD, DM^14*, Nikhil Patkar, MD^15*, Sumeet Gujral, MD^16*, Tanuja Shet^17*, Papagudi Ganesan Subramanian, MD^18*, Jayashree Thorat, MD, DM^19*, Sachin Punatar, MD, DM^10*, Anant Gokarn, MD, DM^11*, Kinjalka Ghosh, MD^20*, Archi Agarwal^21*, Preeti Desai, MD^22*, Shashank Ojha^23*, Subhash Yadav^17*, Shil Pushp Bhosale^24*, Sunil Rajadhyaksha^22*, Anisha Navkudkar, MD^22*, Siddharth Laskar^25*, Sumeet Prakash Mirgh, MD, DM, MBBS^26*, Albeena Nisar, PhD^27*, Deepali Pandit^28*, Ruchira Patil^1*, Rahul Purwar, PhD^2,4*, Sattva S. Neelapu, MD²⁹ and Nirali N. Shah, MD³⁰

¹Department of Medical Oncology, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
²Immunoadoptive Cell Therapy Pvt Ltd (ImmunoACT), Navi Mumbai, India
³Department of Medical Oncology, Tata Memorial Centre Affiliated to Homi Bhabha National Institute, Mumbai, India
⁴Indian Institute of Technology Bombay, Mumbai, India
⁵ImmunoAdoptive Cell Therapy Pvt Ltd, Navi Mumbai, India
⁶Department of Pediatric Oncology, Tata Memorial Center, Affiliated to Homi Bhabha National Institute, Mumbai, India
⁷Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
⁸Tata Memorial Centre Affiliated to Homi Bhabha National Institute, Kharghar, India
⁹Department of Transfusion Medicine, ACTREC, Sector 22, Navi Mumbai, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Navi Mumbai, India
¹⁰Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
¹¹Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
¹²Hematopathology Lab, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
¹³Department of Pathology, Tata Memorial Centre, Mumbai, India
¹⁴Department of Bone Marrow Transplant, ACTREC, Tata Memorial Centre, Navi Mumbai, India
¹⁵Haematopathology Laboratory, Tata Memorial Hospital, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Navi Mumbai, India
¹⁶Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India
¹⁷Department of Pathology, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
¹⁸Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, Maharashtra, India
¹⁹Department of Medical Oncology, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, Maharashtra, India
²⁰Department of Biochemistry, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
²¹Department of Nuclear Medicine, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
²²Department of Transfusion Medicine, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
²³Department of Transfusion Medicine, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Navi Mumbai, India
²⁴Department of Anesthesia and Critical Care Unit, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
²⁵Department of Radiation Oncology, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, India
²⁶BMT Unit, Department of Medical Oncology, ACTREC-Tata Memorial Centre, Navi Mumbai, India
²⁷Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Mumbai, AL, India
²⁸CAR T Cell Centre, Tata Memorial Centre, Affiliated to Homi Bhabha National Institute, Navi Mumbai, India
²⁹Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX
³⁰Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD

Jingjing Feng, MD^1*, Yongxian Hu, M.D., Ph.D.^1*, Mingming Zhang^2*, Heng Cao^3*, Yini Ke^3*, Huijun Xu^1*, Jiazhen Cui^1*, Yanlei Zhang^4*, Alex Hongsheng Chang^4*, Jin Lin^3*, Guoqing Wei, MD^1* and He Huang, Ph.D., M.D.¹

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
³The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
⁴Shanghai YaKe Biotechnology Ltd, Shanghai, China

Yan Qiu^1*, Chong-Sheng Qian^1*, Hai-Xia Zhou^1*, Ming-Zhu Xu^1*, Li-Qing Kang^2*, Ai-Ning Sun, MD, PhD^1*, De-Pei Wu¹, Lei Yu^2* and Shengli Xue^1*

¹The First Affiliated Hospital of Soochow University, Suzhou, China
²Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China

Benedetta Rambaldi^1,2*, Stefania Galimberti, PhD^3*, Giuliana Rizzuto, MD^1,4*, Chiara Francesca Magnani, PhD^5,6*, Chiara Buracchi, PhD, MSc^6*, Giulia Risca^3*, Martina Paredi, MD^6*, Daniela Belotti^7*, Alex Moretti, MD^2,6*, Marianna Ponzo^2,6*, Sarah Tettamanti, PhD^6*, Gian Maria Borleri^1*, Cristian Meli^1*, Muriel Paganessi^1*, Silvia Zaninelli^2,8*, Elisa Gotti^9*, Chiara Capelli^8,10*, Martino Introna, MD^8,9, Federico Lussana, MD, PhD^1*, Giuseppe Gritti, MD, PhD^1*, Silvia Ferrari, MD^1*, Anna Grassi, MD^1*, Sara Napolitano, MD^11*, Adriana Balduzzi, MD¹¹, Maria Grazia Valsecchi, PhD^3*, Giuseppe Dastoli, MD^6*, Alessandro Rambaldi, MD^12,13, Andrea Biondi, MD, PhD^6,7,11 and Giuseppe Gaipa, PhD^6,7

¹Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
²PhD Program in Translational and Molecular Medicine (DIMET), University of Milano-Bicocca, Monza, Italy
³Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
⁴University of Milan, Milano, Italy
⁵Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
⁶Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca/Fondazione MBBM, Monza, Italy
⁷Laboratorio di Terapia Cellulare e Genica Stefano Verri, ASST-Monza, Ospedale San Gerardo, Monza, Italy
⁸USS Centro di Terapia Cellulare "G. Lanzani", Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁹Centro di Terapia Cellulare "G. Lanzani", Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
¹⁰Fondazione per la Ricerca Ospedale di Bergamo (FROM), Bergamo, Italy
¹¹Department of Pediatrics, University of Milano - Bicocca, Fondazione MBBM, Monza, Italy
¹²Department of Oncology and Hematology, University of Milan, Milan, Italy
¹³Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy

Mark B. Geyer, MD^1,2, Briana Cadzin, RN^1*, Kinga Hosszu, PhD^3*, Brigitte Senechal, PhD^4*, Jennifer A. Spross, MA^5*, Alexis Mark^5*, Avinash Desai, MD^5*, Elizabeth R. Cathcart^1*, M. Lia Palomba, MD^1,6 and Neeta Pandit-Taskar, MD^7*

¹Department of Medicine, Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Actinium Pharmaceuticals, Inc., New York, NY
⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY

Sharat Damodar, MBBS, MD, DM¹, Sunil Bhat, MBBS, MD^1*, Akshatha Nayak, MD DM^2*, Pooja Mallya^1*, Bharath Ram S, MBBS, DNB¹, Ravi Joshi^1*, Deepak MB, MD, MBBS^1*, Sudarshan Chougule^1*, Anne Roshan Joseph^3*, Gopinadh Jakka^3*, Sudeshna Dhar^3*, Arun Kumar MG^3*, Murugan Palanisamy^3*, Sri Ramulu Elluru^3*, Mohammed Manzoor Akheel, MPH MBA^3*, Arun Anand^3* and Anil Kamat, MD³

¹Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India
²Department of Haemato-oncology and BMT, Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India
³Immuneel Therapeutics Private Limited, Bengaluru, India

Haiping Dai^1,2,3*, Wei Cui^2,4*, Hongjie Shen, MD, PhD^5*, Qian Wang^6*, Jia Yin^4*, Zheng Li^4*, Depei Wu^2,7 and Xiaowen Tang, MD, PhD^5*

¹Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
²Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
³National Clinical Research Center for Hematologic Diseases, Suzhou, China
⁴National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁵Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China
⁶1. Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China
⁷Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China, Suzhou, China

Aina Oliver-Caldes, MD^1*, Luis Gerardo Rodríguez-Lobato, MD, PhD^2*, Veronica Gonzalez-Calle^3*, Natalia Tovar, MD, PhD^4*, Valentin Cabañas, MD^5*, Paula Rodríguez-Otero, MD, PhD^6*, Juan Luis Reguera, MD^7*, Marta Español-Rego^8*, Beatriz Martin-Antonio, PhD^9*, Aintzane Zabaleta, PhD^10*, Marta Lasa, PhD^11*, Susana Inogés, MD, PhD^11*, Ascensión López-Diaz de Cerio, PhD^11*, Bruno Paiva^12*, Sara Varea^13*, Joaquin Saez-Peñataro^14*, Manel Juan, MD, PhD^8*, Laura Rosiñol, MD, PhD^15*, Felipe Prosper, MD^16*, Jose M. Moraleda, MD, PhD^5*, Álvaro Urbano-Ispizua, MD, PhD¹⁷, Mariona Pascal^8*, Maria-Victoria Mateos, MD¹⁸ and Carlos Fernandez de Larrea, MD²

¹Department of Hematology, Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
²Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain
³Hospital Universitario de Salamanca,Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
⁴Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
⁵Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Arrixaca. University of Murcia, Murcia, Spain
⁶Clínica Universidad de Navarra, Navarra, CCUN, CIMA, IDISNA, CIBER-ONC, Pamplona, Spain
⁷Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
⁸Department of Immunology, Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
⁹Instituto de Investigación Sanitaria-Fundación Jimenez Diaz, Madrid, Spain
¹⁰University of Navarra, IDISNA, CIBERONC, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Pamplona, Spain
¹¹Clínica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IDISNA, CIBERONC Pamplona, Pamplona, Spain
¹²Clinica Universidad de Navarra, Cancer Center Universidad de Navarra (CCUN), Centro de Investigación Medica Aplicada (CIMA), Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain
¹³Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
¹⁴Hospital Clinic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain., Barcelona, Spain
¹⁵Amyloidosis and Myeloma Unit. Department of Hematology. Hospital Clínic de Barcelona. IDIBAPS., Barcelona, Spain
¹⁶Centro de Investigación Médica Aplicada, University of Navarra, Clínica Universidad de Navarra, Pamplona, Spain
¹⁷Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain
¹⁸University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain

Michael Pratta, MS^1*, Lea Burke, MS^1*, John F. DiPersio, MD, PhD², Richard T. Maziarz, MD³, Patricia Feldman, BS^1*, Teresa Brodeur, BS^1*, Cynthia Timmers, PhD^1*, Olga Ivanova, PhD^1*, April Barbour, PhD^1*, Rodica Morariu-Zamfir, MD^1* and Matthew Frigault, MD, MS⁴

¹Incyte Corporation, Wilmington, DE
²Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
³Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁴Massachusetts General Hospital, Dorchester, MA

Sara Ghorashian, FRCPath, PhD^1,2, Giovanna Lucchini, MD^3*, Rachel Richardson, MSc^4*, Kyvi Nguyen, MSc^5*, Craig Terris, BSc^5*, Macarena Oporto-Espuelas, MD^5*, Jenny Yeung, PhD^6*, Danielle Pinner^3*, Jan Chu^3*, Lindsey Williams^7*, Ka-yuk Ko^7*, Chloe Walding^8*, Kelly Watts^9*, Sarah Inglott^10*, Stuart Adams, PhD^11*, Emma Gravett^10*, Kimberly Gilmour, PhD^12*, Alka Lal^13*, Sangeetha Kunaseelan^13*, Bilyana Popova, MSc^14*, Andre Lopes^15*, Yenting Ngai, PhD^16*, Evangelia K Kokalaki, PhD^17*, Milena Balasch Carulla, MD^7*, Khushnuma Mullanfiroze, MD^7*, Arina Lazareva, MD^3*, Vesna Pavasovic, MD^10*, Anupama Rao, MD^10*, Jack Bartram, MD, PhD^10*, Ajay Vora, MD¹⁸, Robert Chiesa, MD^19*, Juliana Silva, MD^7*, Kanchan Rao, MD^3*, Katherine Clesham, MD PhD^20*, Denise Bonney, MD^21*, Robert F Wynn, MD²², Martin Pule, MD, PhD^23*, Rachael E Hough, MD^24* and Persis J Amrolia, MD PhD^7,25*

¹Department of Hematology, Great Ormond Street Hospital for Children, London, United Kingdom
²Developmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, London, ENG, United Kingdom
³Department of Blood and Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom
⁴Molecular and Cellular Immunology Section, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
⁵UCL Great Ormond Street Institute of Child Health, Molecular and Cellular Immunology, London, United Kingdom
⁶UCL Great Ormond Street Institute of Child Health, London, ENG, United Kingdom
⁷Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom
⁸Cancer Clinical Trials Unit, University College London Hospitals NHS Trust, London, United Kingdom
⁹Bone Marrow Transplantation, Royal Manchester Children's Hospital, Manchester, United Kingdom
¹⁰Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
¹¹SIHMDS-Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
¹²Department of Immunology, Great Ormond Street Hospital for Children, London, United Kingdom
¹³CRUK Cancer Trials Centre, University College London, London, United Kingdom
¹⁴CRUK UCL Cancer Trials Centre, UCL, London, United Kingdom
¹⁵Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
¹⁶UCL CRUK Cancer Trials Centre, University College London, London, United Kingdom
¹⁷Autolus Ltd, London, United Kingdom
¹⁸Department of Haematology, The Children's Hospital, London, United Kingdom
¹⁹Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, ENG, United Kingdom
²⁰Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom
²¹Department of Bone Marrow Transplantation, Royal Manchester, Manchester, United Kingdom
²²Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom
²³Cancer Institute, University College London, London, United Kingdom
²⁴Haematology, UCLH, London, United Kingdom
²⁵UCL Great Ormond Street Institute of Child Health, London, United Kingdom

Kai Wang, MD, PhD^1*, Yan Liu^2*, Lung-Ji Chang, PhD³ and Huyong Zheng, MD, PhD⁴

¹Hematology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, CHN
²Baoding Children's Hospital, Baoding, China
³Geno-Immune Medical Institute, Shenzhen, China
⁴Hematology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China

Krina Patel, MD, MSc¹, Nina Shah, MD², Alan Tan, MD^3*, Andrew J Cowan, MD⁴, Cameron J. Turtle, MBBS, PhD^5,6,7, Craig C Hofmeister, MD⁸, Taewoong Choi, MD⁹, Hayder Saeed, MD¹⁰, Julio C. Chavez, MD¹⁰, Matthew J. Pianko, MD¹¹, Mitul Gandhi, MD¹², Sohail A. Chaudhry, MD^13*, Zachary Lee, PharmD^13*, Neha Dixit, PhD^13*, Christie Fanton, PhD^13*, Xiaoli Wang, PhD, MBA^13*, Heng Xu, PhD^13*, Mario Q. Marcondes, MD, PhD¹³, Mary A. Tagliaferri, MD^13*, Jonathan Zalevsky, PhD^14* and Miguel-Angel Perales, MD¹⁵

¹Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
³Rush University Medical Center, Chicago, IL
⁴Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Fred Hutchinson Cancer Research Ctr., Seattle, WA
⁶University of Washington, Seattle, WA
⁷University of Sydney, Camperdown, NSW, Australia
⁸Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
⁹Duke Cancer Institute, Duke University Medical Center, Durham, NC
¹⁰Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
¹¹Rogel Cancer Center, University of Michigan, Ann Arbor, MI
¹²Virginia Cancer Specialists, Gainesville, VA
¹³Nektar Therapeutics, San Francisco, CA
¹⁴Nektar Therapeitics, San Francisco, CA
¹⁵Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Jordan Gauthier, MD^1,2, Nicolas Gazeau^3*, Salvatore Fiorenza, PhD, BSc, FRACP, FRCPA, MBBS, MPH⁴, Erik L. Kimble, MD^4,5, Alexandre Vinaud Hirayama, MD^6,7, Barbara S. Pender, MSc^4*, Henna N Di, BSc^8*, Delaney R. Kirchmeier, BSc^4*, Mazyar Shadman, MD^4,9, Ryan D. Cassaday, MD^8,10, Stanley R. Riddell, MD^2,4, David G. Maloney, MD, PhD^2,8 and Cameron J. Turtle, MBBS, PhD^4,11

¹Fred Hutchinson Cancer Research Center, Seattle, WA, USA, Seattle, WA
²Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Research center, Seattle, WA
⁴Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Department of Medicine/Division of Hematology, University of Washington, Seattle, WA
⁶Fred Hutchinson Cancer Research Center, Seattle, WA
⁷Department of Medical Oncology, University of Washington, Seattle, WA
⁸Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁹Division of Hematology and Medical Oncology, University of Washington, Seattle, WA
¹⁰Department of Medicine, Division of Hematology, University of Washington, Seattle, WA
¹¹Department of Medicine, University of Washington, Seattle, WA

Nicolas Gazeau^1,2,3*, Salvatore Fiorenza, PhD, BSc, FRACP, FRCPA, MBBS, MPH⁴, Erik L. Kimble, MD⁴, Alexandre Vinaud Hirayama, MD⁵, Barbara S. Pender, MSc^4*, Henna A. Di, BSc^4*, Delaney R. Kirchmeier, BSc^4*, Brian G. Till, MD⁶, Mazyar Shadman, MD⁷, Stanley R. Riddell, MD⁴, David G. Maloney, MD, PhD⁵, Cameron J. Turtle, MBBS, PhD⁸ and Jordan Gauthier, MD⁹

¹Clinical Research Division, Fred Hutchinson Cancer Research center, Seattle, WA
²CHRU Lille, Service d'hematologie, Lille, France
³Fred Hutchinson Cancer Research center, Seattle, WA
⁴Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Fred Hutchinson Cancer Research Center, Seattle, WA
⁶University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA
⁷University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
⁸Fred Hutchinson Cancer Research Ctr., Seattle, WA
⁹Clinical Research Division, Fred Hutchinson Cancer Research Ctr., Seattle, WA

Armin Ghobadi, MD¹, Elizabeth L. Budde, MD, PhD², Ahmed Galal, MD³, Kristina Stermer^4*, Allison Bierly, PhD^4*, Sara Ferrando-Martinez, PhD^4*, Byung Ha Lee, PhD^4* and John F. DiPersio, MD, PhD¹

¹Washington University School of Medicine in St. Louis, Siteman Cancer Center, St. Louis, MO
²Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
³Duke University Medical Center, Durham, NC
⁴NeoImmuneTech, Inc., Rockville, MD

Roisin Borrill, MBBS, BSc^1,2*, Helen Campbell^1*, Denise Bonney, MD^1*, Ramya Nataraj^1*, Madeleine Powys^1*, Omima Abdalla Mustafa^1*, Laura Kusyk^1*, Tracy Hussell^2*, Suzy Morton^3*, Simon Stanworth^4*, Kay Poulton^5,6*, Joanne Konkel^2* and Robert Wynn¹

¹Department of Bone Marrow Transplantation, Royal Manchester Children's Hospital, Manchester, United Kingdom
²Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom
³NHS Blood and Transplant, Birmingham, United Kingdom
⁴NHS Blood and Transplant, Oxford, United Kingdom
⁵Transplantation Laboratory, Manchester Royal Infirmary, Manchester, United Kingdom
⁶Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom